SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed bacteriophage therapy that represents a new frontier in...

Researchers in the UK report a clinically-relevant transplantation strategy using CRISPR-corrected human myogenic cells in hydrogels that generate...

A new method for directly editing T-cells in lymph nodes using CRISPR-Cas9 aims to enhance immune checkpoint blockade (ICB) cancer therapies. The...

Scientists engineered nanoparticles capable of delivering genetic material to lung cells with high efficiency when administered intravenously. Based...

Jennifer Doudna and colleagues have engineered a thermostable Cas9 variant, iGeoCas9, which dramatically enhances genome editing efficiency in...

Researchers in South Korea have developed a cadmium selenide (CdSe) quantum dot (Qdot) system to deliver CRISPR-Cas9 for gene editing in microglia,...

A novel engineered TadA ortholog-derived cytosine base editor (aTdCBE) can overcome existing limitations in motif preferences and adenosine activity...

In a recent study, researchers in Italy addressed the critical need for experimental validation of durable epigenetic silencing after transient...